Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,754 evidence items · page 7 / 71

35.1 %Hypertension prevalence in the Tropical highlands agroecological zone of Cameroon was 35.1% [95% CI 28.9–41.3].

Camerounhypertension artériellepublished 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165

925 patientsBy the second year of activity, 925 patients had been registered in the nurse-led pilot clinics for chronic diseases in Cameroon.

Camerounchronic diseasespublished 2009The Pan African medical journaleurope_pmcdocument of 4 observations

5.9 ratioThe total cholesterol/HDL-C ratio was higher in stroke patients compared to controls (5.9 ± 3.5 vs 3.9 ± 1.8).

CamerounAVCpublished 2012Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Aeurope_pmcdocument of 4 observations

9.5 %The risk allele C of TCF7L2 was present in 9.5% of type 2 diabetes mellitus patients and 0% of healthy controls in the Cameroonian study population.

Cameroundiabète de type 2published 2015Journal of diabetes and metabolic disorderseurope_pmcdocument of 5 observations

58.4 %Sixty-six (58.4%) of the patients with diabetes were obese.

Cameroundiabète (non précisé)observed 2019published 2022The Pan African medical journaleurope_pmcdocument of 10 observations

112.3 msSDNN was 112.3 ms in the well-controlled type 2 diabetes group.

Cameroundiabète de type 2published 2018BMC research noteseurope_pmcdocument of 8 observations

4.01 odds_ratioAn association was found between rs5186 and hypertension under homozygous codominant model with odds ratio of 4.01.

Camerounhypertension artériellepublished 2018Journal of clinical hypertension (Greenwich, Conn.)europe_pmcdocument of 3 observations

7.4 %The overall HIV seroprevalence rate in the study population was 7.4% (95% CI 5.2%–10.1%).

CamerounVIH/sidaobserved 2001published 2007Emerging infectious diseasesOpenAlexdocument of 7 observationsDOI 10.3201/eid1303.061069

11 %Over 11% of adults with heart failure have diabetes in sub-Saharan Africa.

Cameroundiabète (non précisé) · insuffisance cardiaquepublished 2008Vascular health and risk managementeurope_pmcdocument of 3 observations

Low-density lipoprotein and total cholesterol were significantly higher in HHV8 DNA-positive than HHV8 DNA-negative participants.

Cameroundiabète (non précisé) · HHV8published 2018Journal of diabeteseurope_pmcdocument of 10 observations

6.5 %Based on body mass index, 6.5% of urban men in Cameroon were obese.

Camerounobésitépublished 2006BMC public healtheurope_pmcdocument of 6 observations

3.5 %Among the 2726 participants, the overall prevalence of obesity was 3.5%.

Camerounobésitépublished 2017BMC public healtheurope_pmcdocument of 9 observations

18.2 %Using the smartphone-based retinal camera, the prevalence of diabetic retinopathy was 18.2%.

Cameroundiabetic retinopathypublished 2019Ophthalmic surgery, lasers & imaging retinaeurope_pmcdocument of 16 observations

1.8 odds_ratioAn association was found between rs699 and hypertension under allele contrast model with odds ratio of 1.80.

Camerounhypertension artériellepublished 2018Journal of clinical hypertension (Greenwich, Conn.)europe_pmcdocument of 3 observations

3 %Obesity was diagnosed in 3.0% of rural women in the studied populations in Cameroon.

Camerounobésitépublished 2002International journal of obesity and related metabolic disorders : journal of the Internateurope_pmcdocument of 6 observations

1,776 adolescentsBetween 2004 and 2010, 1,776 adolescents commenced antiretroviral therapy (ART) at Mpilo OI ART clinic, Bulawayo.

CamerounVIH/sidaobserved 2004 to 2010published 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

2,583 individualsThe study included 2583 SCD patients and healthy controls aged 5–21 years old in Mali, Senegal, Cameroon, Gabon and the Ivory Coast.

Cameroun · Côte d'Ivoire · Gabon · Mali · Sénégaldrépanocytosepublished 2019British journal of haematologyeurope_pmcdocument of 6 observations

8.3 %Among hypertensive participants in Cameroon, 8.3% [95% CI 4.4–12.3] had controlled hypertension during 1994–2010 and 2011–2018 combined.

Camerounhypertension artérielleobserved 1994-2010 and 2011-2018published 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165

20 %Multiple studies have reported lower rates of islet autoantibodies ranging from 20 to 60% amongst people with type 1 diabetes in African populations.

Cameroundiabète de type 1published 2023Frontiers in public healtheurope_pmcdocument of 3 observationsDOI 10.3389/fpubh.2023.1014626

74.7 %The age-standardized awareness rate for coincident hypertension and diabetes was 74.7% among women in a semi-urban population in Bafoussam, Cameroon.

Cameroundiabète (non précisé) · hypertension artérielleobserved 2012published 2014BMC public healtheurope_pmcdocument of 24 observationsDOI 10.1186/1471-2458-14-696

20.8 %Among hypertensive participants in Cameroon, 20.8% [95% CI 14.0–27.7] were aware of their status during 1994–2010 and 2011–2018 combined.

Camerounhypertension artérielleobserved 1994-2010 and 2011-2018published 2019Journal of hypertensioneurope_pmcdocument of 20 observationsDOI 10.1097/hjh.0000000000002165

16.4 %The age-standardized prevalence of hypertension was 16.4% in urban men in Cameroon.

Camerounhypertension artériellepublished 1998International journal of epidemiologyeurope_pmcdocument of 10 observationsDOI 10.1093/ije/27.2.181

80 %Le PSNLP 2011-2015 prévoyait qu’au moins 80 % des cas de fièvre bénéficient d’un diagnostic et d’un traitement appropriés contre le paludisme.

CamerounpaludismeHAL · Unilimdocument of 98 observations

100 %Sensitivity for the detection of proliferative diabetic retinopathy using the smartphone-based retinal camera was 100%.

Camerounproliferative diabetic retinopathypublished 2019Ophthalmic surgery, lasers & imaging retinaeurope_pmcdocument of 16 observations

15,200,000 DALYsIn 2017, liver cancer caused 15.2 million DALYs in men.

Camerouncarcinome hépatocellulaireobserved 2017published 2019JAMA oncologyeurope_pmcdocument of 25 observationsDOI 10.1001/jamaoncol.2019.2996

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.